We are live on ! Find out more
KIA

Kopp Investment Advisors Portfolio holdings

AUM $54.4M
1-Year Est. Return 14.33%
This Fund
S&P 500
This Quarter Est. Return
+12.33%
1 Year Est. Return
+14.33%
3 Year Est. Return
+109.21%
5 Year Est. Return
+340.72%
10 Year Est. Return
AUM
$183M
AUM Growth
-$20.1M
Cap. Flow
-$21.5M
Cap. Flow %
-11.72%
Top 10 Hldgs %
66.27%
Holding
72
New
7
Increased
15
Reduced
40
Closed
6

Sector Composition

Rank Sector Weight
1 Technology 55.8%
2 Healthcare 32.81%
3 Industrials 1.95%
4 Financials 1.85%
5 Consumer Discretionary 1.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXP icon
51
American Express
AXP
$226B
$708K 0.39%
11,536
+12
+0.1% +$698
VTI icon
52
Vanguard Morningstar Total Stock Market ETF
VTI
$689B
$377K 0.21%
3,600
QQQ icon
53
Invesco QQQ Trust
QQQ
$493B
$322K 0.18%
2,950
+250
+9% +$26K
VCSH icon
54
Vanguard Short-Term Corporate Bond ETF
VCSH
$45.1B
$320K 0.17%
4,000
GILD icon
55
Gilead Sciences
GILD
$185B
$289K 0.16%
+3,149
New +$284K
CFMS
56
DELISTED
Conformis, Inc. Common Stock
CFMS
$288K 0.16%
+1,073
New +$284K
LDRH
57
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
$266K 0.15%
+10,422
New +$218K
GE icon
58
GE Aerospace
GE
$356B
$258K 0.14%
1,694
ENTL
59
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$226K 0.12%
+12,403
New +$201K
AAPL icon
60
Apple
AAPL
$4.59T
$221K 0.12%
8,120
EGRX
61
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$218K 0.12%
5,388
+30
+0.6% +$1.9K
SBUX icon
62
Starbucks
SBUX
$122B
$210K 0.11%
3,520
-30
-0.8% -$1.75K
LXRX icon
63
Lexicon Pharmaceuticals
LXRX
$1.03B
$164K 0.09%
13,700
-10
-0.1% -$105
TVTY
64
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$157K 0.09%
15,575
-15
-0.1% -$169
AVDL
65
DELISTED
Avadel Pharmaceuticals
AVDL
$111K 0.06%
+10,033
New +$99.7K
VCYT icon
66
Veracyte
VCYT
$3.64B
$76K 0.04%
14,115
-135
-0.9% -$798
EXAS
67
DELISTED
Exact Sciences
EXAS
-14,140
Closed -$131K
INTC icon
68
Intel
INTC
$487B
-6,644
Closed -$229K
IWO icon
69
iShares Russell 2000 Growth ETF
IWO
$15.1B
-3,575
Closed -$498K
SO icon
70
Southern Company
SO
$102B
-19,505
Closed -$913K
PTX
71
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
-31,529
Closed -$931K
CTCT
72
DELISTED
CONSTANT CONTACT, INC COM
CTCT
-22,489
Closed -$658K

Similar funds

Kopp Investment Advisors's Q1 2016 Portfolio in Review

As of Q1 2016, Kopp Investment Advisors held 72 positions worth $183M, down 9.9% from $203M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Kopp Investment Advisors withdrew a net $21.5M in Q1 2016, closing 6 positions and reducing 40 holdings. Its most notable exit was Pernix Therapeutics Holdings, Inc., an estimated $931K position sold in full.

By sector, the portfolio is most concentrated in Technology at 56% of assets, up from 49% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Kopp Investment Advisors opened a new position in Callidus Software, Inc. worth $2.08M.

  • Kopp Investment Advisors's largest Q1 2016 buy was Callidus Software, Inc.: 124,871 shares worth $2.08M.
  • Kopp Investment Advisors added most to SPS Commerce in Q1 2016, an estimated $452K increase.
  • Kopp Investment Advisors's biggest Q1 2016 reduction was Emcore Corp, cutting an estimated $15.6M.
  • Kopp Investment Advisors fully exited Pernix Therapeutics Holdings, Inc. in Q1 2016, selling an estimated $931K.
  • Kopp Investment Advisors's ten largest holdings make up 66% of its $183M portfolio in Q1 2016.
  • Kopp Investment Advisors opened 7 new positions and closed 6 in Q1 2016.
  • Kopp Investment Advisors's portfolio value fell 9.9% quarter-over-quarter to $183M.

Based on Kopp Investment Advisors's 13F filing for Q1 2016, filed 16 May 2016.